Anti-Aβ Drug Screening Using Human iPS Cell-Derived Neurons for Alzheimer's Disease
Author Information
Author(s): Yahata Naoki, Asai Masashi, Kitaoka Shiho, Takahashi Kazutoshi, Asaka Isao, Hioki Hiroyuki, Kaneko Takeshi, Maruyama Kei, Saido Takaomi C., Nakahata Tatsutoshi, Asada Takashi, Yamanaka Shinya, Iwata Nobuhisa, Inoue Haruhisa
Primary Institution: Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
Hypothesis
Can human iPS cell-derived neuronal cells be used to model Alzheimer's disease and screen for anti-Aβ drugs?
Conclusion
The study shows that hiPS cell-derived neuronal cells express functional secretases involved in Aβ production, making them suitable for drug screening.
Supporting Evidence
- hiPS cell-derived neuronal cells express functional β- and γ-secretases involved in Aβ production.
- Aβ production was inhibited by β-secretase and γ-secretase inhibitors.
- Different susceptibilities to drugs were observed between early and late differentiation stages.
Takeaway
Scientists created brain cells from special stem cells to study Alzheimer's disease and test new medicines that might help treat it.
Methodology
Human iPS cells were differentiated into neuronal cells, which were then tested for Aβ production and response to secretase inhibitors.
Limitations
The study primarily focuses on specific differentiation stages and may not represent all aspects of Alzheimer's pathology.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website